Follow us on X
Follow us on LinkedIn
Follow us on Youtube
Discover RISE d.o.o

BuruliVac

Identification and development of vaccine candidates for Buruli Ulcer Disease


Description

BuruliVac aims at identifying and developing novel vaccine candidates against M. ulcerans, a bacterium causing Buruli Ulcer Disease (BUD), the third most common mycobacterial disease in immunocompetent humans. BUD is a necrotising disease of the skin that produces massive ulcers and permanent disabling scars. A vaccine against M. ulcerans would protect persons at risk in highly endemic areas and could be used as a therapeutic vaccine to shorten duration of treatment and to prevent relapses.

Coordinator
Prof. Bernhard Fleischer
Email
Programme
FP7
Duration
39 months (March 2010 - May 2013)
Project funding
€ 4,599,983.00
Project partners
16
About Eurice

Eurice offers knowledge-based consultancy services in project and innovation management.

Eurice Head Office
Heinrich-Hertz-Allee 1
66386 St. Ingbert
Germany
Phone: +49 6894 388130
Email
Eurice Berlin
Alt-Reinickendorf 25
13407 Berlin
Germany
Phone: +49 30 374415840
Email